Lenalidomide

Lenalidomide Reactions 1680, p199 - 2 Dec 2017 Pulmonary embolism, deep vein thrombosis and cardiac arrest: case report In a retrospective study of clinical trial NCT02341781 (MCL-004 study), a 68-year-old man was described, who developed pulmonary embolism, deep vein thrombosis (DVT) and cardiac arrest during treatment with lenalidomide [IMid]. Subsequently, he died. The man, who had a history of mantle cell lymphoma, was started on oral lenalilomide [dosage not stated]. Two months after the start of the treatment, he had a partial response. However, 83 days after the first dose of lenalidomide, he died because of pulmonary embolism, which was suspected to be related to the lenalidomide. Additionally, he experienced grade five adverse events deep vein thrombosis and cardiac arrest. Author comment: "This patient had a (partial response) 2 months after lenalidomide initiation but died due to a pulmonary embolism, suspected to be related to lenalidomide therapy, as well as had incidences of other grade 5 AEs (DVT and cardiac arrest). " Wang M, et al. Observational study of lenalidomide in patients with mantle cell lymphoma who relapsed/progressed after or were refractory/intolerant to ibrutinib (MCL-004). Journal of Hematology and Oncology 10: 171, 2 Nov 2017. Available from: URL: http://doi.org/10.1186/s13045-017-0537-5 - USA 803284562 0114-9954/17/1680-0001/$14.95 Adis © 2017 Springer International Publishing AG. All rights reserved Reactions 2 Dec 2017 No. 1680 http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Reactions Weekly Springer Journals

Lenalidomide

Reactions Weekly , Volume 1680 (1) – Dec 2, 2017
Free
1 page

Loading next page...
1 Page
 
/lp/springer_journal/lenalidomide-SS1AQr7BWa
Publisher
Springer Journals
Copyright
Copyright © 2017 by Springer International Publishing AG, part of Springer Nature
Subject
Medicine & Public Health; Drug Safety and Pharmacovigilance; Pharmacology/Toxicology
ISSN
0114-9954
eISSN
1179-2051
D.O.I.
10.1007/s40278-017-39130-6
Publisher site
See Article on Publisher Site

Abstract

Reactions 1680, p199 - 2 Dec 2017 Pulmonary embolism, deep vein thrombosis and cardiac arrest: case report In a retrospective study of clinical trial NCT02341781 (MCL-004 study), a 68-year-old man was described, who developed pulmonary embolism, deep vein thrombosis (DVT) and cardiac arrest during treatment with lenalidomide [IMid]. Subsequently, he died. The man, who had a history of mantle cell lymphoma, was started on oral lenalilomide [dosage not stated]. Two months after the start of the treatment, he had a partial response. However, 83 days after the first dose of lenalidomide, he died because of pulmonary embolism, which was suspected to be related to the lenalidomide. Additionally, he experienced grade five adverse events deep vein thrombosis and cardiac arrest. Author comment: "This patient had a (partial response) 2 months after lenalidomide initiation but died due to a pulmonary embolism, suspected to be related to lenalidomide therapy, as well as had incidences of other grade 5 AEs (DVT and cardiac arrest). " Wang M, et al. Observational study of lenalidomide in patients with mantle cell lymphoma who relapsed/progressed after or were refractory/intolerant to ibrutinib (MCL-004). Journal of Hematology and Oncology 10: 171, 2 Nov 2017. Available from: URL: http://doi.org/10.1186/s13045-017-0537-5 - USA 803284562 0114-9954/17/1680-0001/$14.95 Adis © 2017 Springer International Publishing AG. All rights reserved Reactions 2 Dec 2017 No. 1680

Journal

Reactions WeeklySpringer Journals

Published: Dec 2, 2017

References

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Search

Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly

Organize

Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.

Access

Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

DeepDyve

Freelancer

DeepDyve

Pro

Price

FREE

$49/month
$360/year

Save searches from
Google Scholar,
PubMed

Create lists to
organize your research

Export lists, citations

Read DeepDyve articles

Abstract access only

Unlimited access to over
18 million full-text articles

Print

20 pages / month

PDF Discount

20% off